Jeantet advises investment funds Orbimed and MorningSide Ventures in connection with €39 million financing of Enyo Pharma
Paris, January 8, 2024 – Jeantet advised investment funds OrbiMed and Morningside Ventures in connection with the Series C financing of French biopharmaceutical company ENYO Pharma.
ENYO Pharma, a clinical-stage biopharmaceutical company developing proprietary medicines to improve quality of life and avoid end-stage renal failure and dialysis in patients with kidney disease, announced on January 3, 2024 a €39 million Series C, co-led by investment companies OrbiMed and Morningside, with the participation of the company’s historical shareholders.
ENYO also announced that it had received Investigational New Drug (IND) designation from the U.S. Food and Drug Administration (FDA) to initiate a Phase 2 clinical trial on Vonafexor, a highly selective FXR agonist, for the treatment of Alport syndrome. This is a major milestone for ENYO.
Jeantet advises BOSSARD group on the acquisition of AERO NEGOCE INTERNATIONAL group
Paris, July 24, 2024 – Jeantet has advised the Swiss Bossard Group, a leading global provider of product solutions and services in the field of industrial fastening and assembly technology listed on SIX Swiss Exchange (BOSN), in the signing of an agreement for the acquisition of the French group Aero Negoce International (ANI). Aero Negoce […]
| CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises GROUPE ELIOR in its acquisition of DEMOULIN TRAITEUR
Paris, 19 July, 2024 – Jeantet has advised the Elior group, one of the world’s leading contract caterers, on its acquisition of Démoulin Traiteur, a high-end catering services company. Growing rapidly since its creation in 1991 and its takeover by the Derichebourg group in 2023, Elior, a publicly listed French group specializing in contract catering, […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advised IST on the sale of three wind farm projects in France
Paris, 9 July, 2024 – Jeantet advised IST, a Swiss independent investment foundation, on the sale of three wind farm projects to Volta group. Jeantet assisted IST in the sale to the French Volta group (an independent developer and producer of renewable energy) of three wind farms in France with a combined total capacity of […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advised IQEQ MANAGEMENT on the implementation of a trust solution (Fiducie-Gestion) by CARMAT in accordance with its agreement entered into with all its financial creditors, including the european investment bank, on new repayment terms for its bank loans
Paris, on June 21 2024 – Jeantet advised IQEQ Management, an AMF-accredited management company, as trustee, in connection with the implementation of a trust solution (fiducie-gestion) by Carmat, in accordance with the final agreement entered into on March 22, 2024 with its financial creditors, including the European Investment Bank, on new repayment terms for its […]
Paris | CAPITAL MARKETS AND STOCK EXCHANGE LAW
Jeantet advised ANANDA IMPACT VENTURES and CONTRARIAN VENTURES on the EUR 3.6 million SSED round of DECADE ENERGY
Jeantet advised Ananda Impact Ventures and Contrarian Ventures on the EUR 3.6 million seed round of Decade Energy. Decade Energy is a French start-up providing logistics companies with holistic, reliable and cost-efficient solutions that enable the electrification of commercial electric vehicle fleets, aiming to the decarbonation of logistic fleets. The company is headquartered in Paris, […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advised PLENIUM PARTNERS and SWEN CAPITAL PARTNERS in the fundraising of €87 million of SMART ENERGIES to accelerate its development
Paris, 7 June, 2024 – Jeantet advised Plenium Partners’ and SWEN Capital Partners’ funds in their investment in Smart Energies, a French leading solar IPP, alongside the long-standing historical shareholders of Smart Energies, and RGREEN INVEST, which has supported the group since 2022. The capital increase amounts to €87 million and will accelerate the deployment […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises Pegase Healthcare in connection with its acquisition of the Com&Co Group
Paris, May 31, 2024 – Jeantet advised Pegase Healthcare, a strategy and communications consultancy firm that supports transformations in the healthcare sector, in LBO with Turenne Santé since 2022, on the acquisition of Com&Co, a Marseille-based player in medical training and conference organizer with sales of almost €10 million. This external growth will enable the […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises PULLUP ENTERTAINMENT in the context of its share capital increase without preferential subscription rights by way of a public offering and with a priority period, on an irreducible basis only, for its existing shareholders, for a total amount of circa €23 million
Paris, May 31, 2024 – Jeantet advised PulluP Entertainment, one of the European leaders in the publishing and development of video games iii – AA for PC and Consoles, in the context of its share capital increase without preferential subscription rights of the shareholders by way of a public offering and with a priority period, […]
Paris | CAPITAL MARKETS AND STOCK EXCHANGE LAW
Jeantet advises OSMOZIS and its controlling shareholders in the context of the entry into exclusive negotiations with the PASSMAN GROUP for the acquisiton by the PASSMAN GROUP of a majority block, prior to the filing of a simplified tender offer on OSMOZIS shares
Paris, May 24, 2024 – Jeantet has advised Osmozis (a company listed on the Euronext Growth Paris market), specialized in the digital transformation of campsites and holiday homes in Europe, as well as its controlling shareholders, in the context of the acquisition project of a majority block of Osmozis shares by the Passman Group, a […]
| CAPITAL MARKETS AND STOCK EXCHANGE LAW
Jeantet advised SEE YOU SUN on its EUR 46 MILLION fundraising
Paris, 6 May, 2024 – Jeantet advised See You Sun, a photovoltaic developer and producer, on a new EUR 46 million round of financing with la Banque des Territoires and Demeter (its historical investors). This new round of financing which follows an initial fundraising of EUR 12 million in 2021 establishes to EUR 58 million […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises DEUTSCHE TELEKOM on its partnership with EQUATIV
Paris, April 25 2024 – Jeantet advised Deutsche Telekom on its partnership with Equativ, the leading independent adtech platform for programmatic advertising, in which Bridgepoint Development Capital is the majority shareholder. This is a strategic alliance between the French adtech company Equativ and the German telecom giant Deutsche Telekom. By combining their strengths and expertise, […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advised OMNES in setting up its partnership with STONEHEDGE
Paris, 15 April, 2024 – Jeantet advised Omnes, a leading private equity firm dedicated to energy transition and innovation, in the context of its partnership with Stonehedge to create Mégalithe, a joint venture dedicated to developing Class A logistics projects with high environmental standards in France. Through Construction Energie Plus 2, its fund dedicated to […]
Paris | CORPORATE – M&A – PRIVATE EQUITY